DFFVX | DFSVX | DFFVX / DFSVX | |
Total Expense Ratio | 0.29 | 0.31 | 94% |
Annual Report Gross Expense Ratio | 0.30 | 0.31 | 97% |
Fund Existence | 25 years | 32 years | - |
Gain YTD | -5.208 | -6.267 | 83% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 12.9B | 15.3B | 84% |
Annual Yield % from dividends | 1.42 | 1.51 | 94% |
Returns for 1 year | -0.29 | -1.45 | 20% |
Returns for 3 years | 9.66 | 6.45 | 150% |
Returns for 5 years | 145.41 | 130.47 | 111% |
Returns for 10 years | 49.03 | 32.66 | 150% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
FXF | 100.67 | 0.28 | +0.28% |
Invesco CurrencyShares® Swiss Franc | |||
CMCI | 25.48 | N/A | N/A |
VanEck® CMCI Commodity Strategy ETF | |||
UMAY | 33.78 | -0.06 | -0.18% |
Innovator U.S. Equity Ultra BffrETF™-May | |||
BMEZ | 14.96 | -0.09 | -0.60% |
BlackRock Health Sciences Term Trust | |||
TECB | 50.45 | -0.44 | -0.86% |
iShares US Tech Breakthrough Mltsctr ETF |